Attovia Therapeutics (ATTO US)

Analysis

Health Care • United States

Attovia Therapeutics, Inc. is a biotechnology company. The Company focuses on research and development of therapeutic products for the treatment of patients with high unmet need across immune mediated diseases. Attovia Therapeutics operates in the United States.

Refresh

Exchange Announcement • 03 Sep 2026 04:21

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 03 Sep 2026 04:17

Current Report (Form 8-K | Period ending 2026-09-02)

Exchange Announcement • 07 Aug 2026 04:12

Current Report (Form 8-K | Period ending 2026-08-06)

Exchange Announcement • 04 Aug 2026 18:59

S-1/A | IPO Registration (Amendment)

No more filings

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00